228 related articles for article (PubMed ID: 28096629)
1. Induced pluripotent stem cells as a cellular model for studying Down Syndrome.
Brigida AL; Siniscalco D
J Stem Cells Regen Med; 2016; 12(2):54-60. PubMed ID: 28096629
[TBL] [Abstract][Full Text] [Related]
2. [Progress of research on induced pluripotent stem cell models for Down syndrome].
Zhang T; Kong L; Sun G; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1183-1185. PubMed ID: 32924131
[TBL] [Abstract][Full Text] [Related]
3. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
4. Cell models for Down syndrome-Alzheimer's disease research.
Wu Y; West NR; Bhattacharyya A; Wiseman FK
Neuronal Signal; 2022 Apr; 6(1):NS20210054. PubMed ID: 35449591
[TBL] [Abstract][Full Text] [Related]
5. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
6. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
7. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
[TBL] [Abstract][Full Text] [Related]
8. Generation of two induced pluripotent stem cell lines from patients with Down syndrome.
Zhu W; Liu W; Yu R; Manning M; Waran Romfh A; Wu JC
Stem Cell Res; 2023 Oct; 72():103204. PubMed ID: 37734318
[TBL] [Abstract][Full Text] [Related]
9. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel.
Lana-Elola E; Watson-Scales S; Slender A; Gibbins D; Martineau A; Douglas C; Mohun T; Fisher EM; Tybulewicz VL
Elife; 2016 Jan; 5():. PubMed ID: 26765563
[TBL] [Abstract][Full Text] [Related]
11. Lower Oncogenic Potential of Human Mesenchymal Stem Cells Derived from Cord Blood Compared to Induced Pluripotent Stem Cells.
Foroutan T; Najmi M; Kazemi N; Hasanlou M; Pedram A
Int J Organ Transplant Med; 2015; 6(3):99-104. PubMed ID: 26306155
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of Down syndrome.
Patterson D
Hum Genet; 2009 Jul; 126(1):195-214. PubMed ID: 19526251
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine.
Honda A; Hirose M; Hatori M; Matoba S; Miyoshi H; Inoue K; Ogura A
J Biol Chem; 2010 Oct; 285(41):31362-9. PubMed ID: 20670936
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of somatic cells to pluripotency.
Nakagawa M; Yamanaka S
Adv Exp Med Biol; 2010; 695():215-24. PubMed ID: 21222208
[TBL] [Abstract][Full Text] [Related]
15. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.
Chang MY; Kim D; Kim CH; Kang HC; Yang E; Moon JI; Ko S; Park J; Park KS; Lee KA; Hwang DY; Chung Y; Lanza R; Kim KS
PLoS One; 2010 Mar; 5(3):e9838. PubMed ID: 20352099
[TBL] [Abstract][Full Text] [Related]
16. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
[TBL] [Abstract][Full Text] [Related]
17. Chick derived induced pluripotent stem cells by the poly-cistronic transposon with enhanced transcriptional activity.
Katayama M; Hirayama T; Tani T; Nishimori K; Onuma M; Fukuda T
J Cell Physiol; 2018 Feb; 233(2):990-1004. PubMed ID: 28387938
[TBL] [Abstract][Full Text] [Related]
18. Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association.
Pelleri MC; Locatelli C; Mattina T; Bonaglia MC; Piazza F; Magini P; Antonaros F; Ramacieri G; Vione B; Vitale L; Seri M; Strippoli P; Cocchi G; Piovesan A; Caracausi M
BMC Med Genomics; 2022 Dec; 15(1):266. PubMed ID: 36544206
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
20. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
